SET Announcements

The latest company disclosures have been updated, offering investors and stakeholders timely access to essential information.
14 August 2025
Financial Performance Quarter 2 (F45) (Reviewed)
14 August 2025
Financial Statement Quarter 2/2025 (Reviewed)
14 August 2025
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
14 August 2025
Declaration of interim dividend of 2025
30 July 2025
Report of the utilization of capital increase from IPO
14 May 2025
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
14 May 2025
Financial Performance Quarter 1 (F45) (Reviewed)
14 May 2025
Financial Statement Quarter 1/2025 (Reviewed)
18 April 2025
Publication of the Minutes of the 2025 Annual General Meeting of Shareholders on the Company's Website
04 April 2025
Notification of the Resolutions of the 2025 Annual General Meeting of Shareholders
31 March 2025
Mega Lifesciences Public Company Limited ("MEGA") confirms that there is no impact of earthquake on its employees, assets and business continuity. (revised version)
31 March 2025
Mega Lifesciences Public Company Limited ("MEGA") confirms that there is no impact of earthquake on its employees, assets and business continuity.